Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases. Its marketed products include EYLEA HD and EYLEA (aflibercept) for eye diseases, Dupixent (dupilumab) for allergic and inflammatory diseases, Libtayo (cemiplimab) for cancers, Praluent (alirocumab) for cardiovascular risk, Kevzara (sarilumab) for rheumatoid arthritis, and others. The company reported revenues of $14.3 billion in 2024.
expected 2026-08-03
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | REGN | discussed Blockchain & Crypto | |
| topic_mention | REGN | discussed Networking | |
| topic_mention | REGN | discussed Regulation | |
| topic_mention | REGN | discussed Automotive | |
| topic_mention | REGN | discussed Healthcare & Bio | |
| topic_mention | REGN | discussed Platform & Ecosystem | |
| guidance | REGN | guided expect a continuation of this trend with reimbursements from manufacturing of commercial supplies expected to be sequentially lower by approximately $40 million | |
| guidance | REGN | guided expect continued improvements in profitability from the Sanofi collaboration, which will continue to accelerate the paydown of the antibody development balance, | |
| outlook | REGN | stated we anticipate will drive additional uptake | |
| outlook | REGN | stated we expect significant category and competiti ve pressures that negatively impact U | |
| company_mention | REGN | mentioned AMD | |
| topic_mention | REGN | discussed Blockchain & Crypto | |
| topic_mention | REGN | discussed Networking | |
| topic_mention | REGN | discussed Supply Chain | |
| topic_mention | REGN | discussed Regulation | |
| topic_mention | REGN | discussed Gaming | |
| topic_mention | REGN | discussed Automotive | |
| topic_mention | REGN | discussed Healthcare & Bio | |
| topic_mention | REGN | discussed AI Compute | |
| topic_mention | REGN | discussed Platform & Ecosystem |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-04 | 2025-12-31 | 0000872589-26-000008 | EDGAR | 93K words |
| 2025-02-05 | 2024-12-31 | 0001804220-25-000011 | EDGAR | — |
| 2024-02-05 | 2023-12-31 | 0001804220-24-000009 | EDGAR | — |
| 2023-02-06 | 2022-12-31 | 0001804220-23-000008 | EDGAR | — |
| 2022-02-07 | 2021-12-31 | 0001804220-22-000007 | EDGAR | — |
| 2021-02-08 | 2020-12-31 | 0001804220-21-000008 | EDGAR | — |
| 2020-02-07 | 2019-12-31 | 0001532176-20-000008 | EDGAR | — |
| 2019-02-07 | 2018-12-31 | 0001532176-19-000009 | EDGAR | — |
| 2018-02-08 | 2017-12-31 | 0001532176-18-000013 | EDGAR | — |
| 2017-02-09 | 2016-12-31 | 0001532176-17-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0000872589-26-000025 | EDGAR | — |
| 2026-04-29 | 2026-03-31 | 0000872589-26-000016 | EDGAR | — |
| 2025-10-28 | 2025-09-30 | 0000872589-25-000028 | EDGAR | 58K words |
| 2025-08-01 | 2025-06-30 | 0000872589-25-000019 | EDGAR | — |
| 2025-04-29 | 2025-03-31 | 0001804220-25-000022 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001804220-24-000040 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001804220-24-000028 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001804220-24-000017 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0001804220-23-000031 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001804220-23-000023 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001804220-23-000016 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001804220-22-000031 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0000872589-26-000023 | EDGAR | — |
| 2026-07-06 | 0001104659-26-080562 | EDGAR | — |
| 2026-06-17 | 0001104659-26-075127 | EDGAR | — |
| 2026-04-29 | 0000872589-26-000014 | EDGAR | — |
| 2026-04-08 | 0001104659-26-040661 | EDGAR | 1K words |
| 2026-01-30 | 0000872589-26-000004 | EDGAR | 10K words |
| 2026-01-12 | 0001104659-26-002691 | EDGAR | — |
| 2025-10-28 | 0000872589-25-000026 | EDGAR | — |
| 2025-10-06 | 0001104659-25-096921 | EDGAR | — |
| 2025-08-01 | 0000872589-25-000017 | EDGAR | — |
143 total filings indexed. 111 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript | |
| — | REGN Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000872589 |
| Ticker | REGN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NY |
| Website | https://www.regeneron.com |
| Listed | 1991-04-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/REGN (~200 tokens, structured JSON with cryptographic provenance)